Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BRCA2 mutation + TP53 mutation
i
Other names:
BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset, TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7157
;
675
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
TP53 expression (4)
TP53 overexpression (4)
BRCA2 overexpression (2)
ROS1 positive + TP53 positive (1)
TP53 overexpression + CD5 overexpression (1)
BRCA2 expression (1)
BRCA2 positive (1)
BRCA2 underexpression (1)
TP53 expression (4)
TP53 overexpression (4)
BRCA2 overexpression (2)
ROS1 positive + TP53 positive (1)
TP53 overexpression + CD5 overexpression (1)
BRCA2 expression (1)
BRCA2 positive (1)
BRCA2 underexpression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BRCA2 mutation + TP53 mutation
Prostate Cancer
BRCA2 mutation + TP53 mutation
Prostate Cancer
rucaparib
Sensitive: C3 – Early Trials
rucaparib
Sensitive
:
C3
rucaparib
Sensitive: C3 – Early Trials
rucaparib
Sensitive
:
C3
BRCA2 mutation + TP53 mutation
Colorectal Cancer
BRCA2 mutation + TP53 mutation
Colorectal Cancer
mFOLFOX6
Resistant: C3 – Early Trials
mFOLFOX6
Resistant
:
C3
mFOLFOX6
Resistant: C3 – Early Trials
mFOLFOX6
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.